NIVF News & Events

NewGenIVF Group announced that it has executed a share purchase agreement and an exclusive agency agreement with K25.ai. Under the share purchase agreement, NewGen will acquire an initial 2% equity interest in K25.ai for $2M, implying a $100M valuation, with the right to increase its ownership to up to 10% on the same valuation terms. NewGen believes the investment provides strategic participation in an emerging prediction and information-market platform while maintaining a measured level of equity exposure. The exclusive agency agreement is expected to serve as the primary commercial foundation of the relationship. Through the exclusive agency agreement, NewGen is appointed as K25.ai's exclusive agency partner for promotion, marketing and business facilitation in selected permitted APAC markets, creating a potential participation channel for NewGen from customers it introduces, with a three-year initial term and renewal upside.

NewGenIvf Group Ltd trading halted, news pending

NewGenIvf Group files to sell 100M Class A ordinary shares for holders

NewGenIVF Group announced that it has entered into a Memorandum of Understanding, MOU, with Women in Web3 Hong Kong Limited, a leading community organization dedicated to advancing women and their allies in Hong Kong's Web3 ecosystem. Under the MOU, NewGen and WiW3 intend to collaborate on a co-branded public awareness and education campaign anchored by the NewGen manifesto and petition, with a primary focus on women's health literacy. "Women's health should be part of everyday conversations, not last-minute crises," said Alfred Siu, Chief Executive Officer of NewGen. "Collaborating with Women in Web3 Hong Kong helps bring these discussions into the heart of Hong Kong's innovation community, where we have a chance to educate a significant number of women on making informed choices and engaging in long-term family planning and overall wellness."